1. Wang, Ya-Juan, Liu, Man, Jiang, Hui-Ying, Yu, Yong-Wei. 2022. Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer. In Journal of oncology, 2022, 5848823. doi:10.1155/2022/5848823. https://pubmed.ncbi.nlm.nih.gov/35794979/
2. Zhang, Yitong, Wang, Jiaxing, Liu, Xiqing. 2020. LRRC19-A Bridge between Selenium Adjuvant Therapy and Renal Clear Cell Carcinoma: A Study Based on Datamining. In Genes, 11, . doi:10.3390/genes11040440. https://pubmed.ncbi.nlm.nih.gov/32316597/
3. Sun, Jie, Wang, Zhijing, Wang, Xirui. 2018. Suppression of LRRC19 promotes cutaneous wound healing in pressure ulcers in mice. In Organogenesis, 14, 13-24. doi:10.1080/15476278.2018.1436924. https://pubmed.ncbi.nlm.nih.gov/29461900/
4. Dong, Yue, Meng, Fanyi, Wang, Jingyi, Zhong, Weilong, Cao, Hailong. 2024. Desulfovibrio vulgaris flagellin exacerbates colorectal cancer through activating LRRC19/TRAF6/TAK1 pathway. In Gut microbes, 17, 2446376. doi:10.1080/19490976.2024.2446376. https://pubmed.ncbi.nlm.nih.gov/39718561/
5. Zhang, YunQiang, Tang, MingYang, Guo, Qiang, Yang, ZhiYong, Li, Dan. 2022. The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis. In Gene, 816, 146173. doi:10.1016/j.gene.2021.146173. https://pubmed.ncbi.nlm.nih.gov/35026294/
6. Rajeshkumar, N V, Tan, Aik Choon, De Oliveira, Elizabeth, Messersmith, Wells A, Hidalgo, Manuel. 2009. Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer. In Clinical cancer research : an official journal of the American Association for Cancer Research, 15, 4138-46. doi:10.1158/1078-0432.CCR-08-3021. https://pubmed.ncbi.nlm.nih.gov/19509160/
7. Yin, Teng-Fei, Zhao, Dong-Yan, Zhou, Yuan-Chen, Wang, Qian-Qian, Yao, Shu-Kun. . Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer. In World journal of clinical cases, 9, 4520-4541. doi:10.12998/wjcc.v9.i18.4520. https://pubmed.ncbi.nlm.nih.gov/34222420/
智鼠故事 
